Clearance Summary
CryoTreQ received FDA 510(k) clearance under submission number K202038, sponsored by VitreQ BV. The device was reviewed via the Traditional premarket notification pathway and assigned to the Ophthalmic review panel. The statutory decision date of record is 2020-12-30.
- Submission: K202038
- Applicant / Sponsor: VitreQ BV
- Clearance pathway: Traditional
- Review panel: Ophthalmic
- Device class: Class II
- Regulation citation: 21 CFR 886.4170
- Decision date: 2020-12-30
Classification & Regulation
This clearance is catalogued under FDA product code HPS and 21 CFR 886.4170, within the Ophthalmic review panel as a Class II device.